TechCrunch is reporting that Jawbone is preparing to exit the low-margin fitness bands market sold directly to consumers, to focus on the high-margin business to business to consumer model, Specifically, enterprise medical devices and associated services sold directly to clinicians and health providers working with patients.
MobiHealthNews opines that Jawbone is working on their clinically-focused wearable, building on their 2015 acquisition of Spectros. Spectros specialized in application of spectroscopy in non-invasive molecular sensors for use in pulse oximetry and detection of perfusion and ischemia. Spectros, was a startup founded by Jawbone’s Chief Medical Officer David Benaron.
Jawbone is currently seeking additional funding to support their new initiative. Another entry into the lucrative wearable medical device marketplace.
For more information see: